Key result
Postmenopausal status is linked to adverse cardiometabolic risk profiles and higher Framingham risk scores.
Why the study?
How does the cardiometabolic risk profile differ between premenopausal and postmenopausal women?
Cross-Sectional
How does the cardiometabolic risk profile differ between premenopausal and postmenopausal women?
Answers are grounded in this paper and cite their sources.
Post-menopausal women exhibit an altered cardiometabolic risk profile with higher Framingham risk scores and adverse anthropometric and hemodynamic changes compared to premenopausal women.
OBJECTIVE: The study was designed to determine and compare the cardiometabolic risk in premenopausal and postmenopausal women. METHODS: Data were collected using cross-sectional and correlational study. In this study, the sociodemographic characteristics, anthropometric measurements, and biochemical parameters of menopausal women were examined. RESULTS: The average age of menopausal women is higher compared to premenopausal women. Menopausal duration, number of children, daily cigarette consumption, body weight, body mass index (BMI), waist circumference, hip circumference, waist-to-hip ratio, systolic and diastolic blood pressure, fasting blood glucose, hemoglobin, AST (aspartate aminotransferase), and Framingham risk score are higher in menopausal women compared to premenopausal women. Conversely, height, HDL (high-density lipoprotein) level, LDL (low-density lipoprotein) level, TSH (thyroid-stimulating hormone), ALT (alanine aminotransferase), HbA1c (glycated hemoglobin), serum albumin, and visceral adiposity index (VAI) values are lower in menopausal women compared to premenopausal women. CONCLUSION: These findings indicate changes in the metabolic profiles of menopausal women. This study could serve as an important resource for assessing the health status of menopausal women and for implementing appropriate measures. CLINICAL TRIAL NUMBER: not applicable.
No takes yet. Share an insight, caveat, or question.
Orhan et al. (2025) conducted a cross-sectional in Cardiometabolic risk. Postmenopausal status vs. Premenopausal status was evaluated on Cardiometabolic risk profile. Postmenopausal status was associated with higher cardiometabolic risk markers, including BMI, blood pressure, fasting glucose, and Framingham risk score, compared to premenopausal status.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: